Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent.

Antimicrobial Agents and Chemotherapy
D E SentochnikR C Moellering

Abstract

The comparative in vitro activity of SM7338 was tested against 670 routine clinical isolates and 130 cefoperazone-resistant isolates of bacteria by agar dilution methods. SM7338 was at least as active as imipenem against gram-negative organisms but was slightly less active against gram-positive organisms. SM7338 was particularly active against members of the family Enterobacteriaceae, with MICs for 90% of strains of less than or equal to 0.125 micrograms/ml for all species tested. Differences in activity between SM7338 and imipenem were particularly striking against Proteus vulgaris, Proteus mirabilis, and Morganella morganii, against which MICs of SM7338 and imipenem for 90% of strains were 0.125 and 4 micrograms/ml, respectively. The presence of unique plasmid-mediated beta-lactamases in Pseudomonas aeruginosa PU21 transconjugants did not affect activity substantially, except in the case of OXA-2 (eightfold-increased MIC) and OXA-3 (fourfold-increased MIC). SM7338 was also active against a laboratory-derived strain of P. aeruginosa which hyperproduced chromosomal beta-lactamase, inhibiting both the wild type and the mutant at a concentration of 1.0 micrograms/ml.

References

Apr 1, 1986·The Journal of Antimicrobial Chemotherapy·A M PhilipponG A Jacoby
Nov 1, 1986·The Journal of Infectious Diseases·C C Sanders, W E Sanders
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·H C NeuN M Neu
Sep 1, 1986·Antimicrobial Agents and Chemotherapy·R Wise
May 1, 1985·Antimicrobial Agents and Chemotherapy·A A MedeirosG A Jacoby
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·C I BustamanteH C Standiford
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·A YotsujiS Mitsuhashi
Dec 1, 1983·The Journal of Antimicrobial Chemotherapy·S Mitsuhashi
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·Y SainoS Mitsuhashi
Feb 1, 1982·The Journal of Antimicrobial Chemotherapy·G M EliopoulosR C Moellering
Nov 1, 1980·Antimicrobial Agents and Chemotherapy·R D PearsonS W Chapman

❮ Previous
Next ❯

Citations

Jan 1, 1992·European Journal of Clinical Pharmacology·A LeroyG Humbert
Jan 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F SarubbiA Verghese
Jul 1, 1990·Diagnostic Microbiology and Infectious Disease·G M EliopoulosM L Grayson
Aug 1, 1997·Journal of the American Academy of Dermatology·M E EpsteinN S Sadick
Feb 6, 1999·Diagnostic Microbiology and Infectious Disease·S C ChangW C Hsieh
Dec 1, 1992·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·C LangG Pulverer
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·K UbukataS Mitsuhashi
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·J H JorgensenA W Howell
Dec 1, 1991·Antimicrobial Agents and Chemotherapy·A GudmundssonS Gudmundsson
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·M HikidaS Kuwao
Jul 1, 1992·Antimicrobial Agents and Chemotherapy·H C NeuN X Chin
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·S NakagawaN Tanaka
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·G MalanoskiG M Eliopoulos
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·A NovelliT Mazzei
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Tetsufumi KogaSyogo Kuwahara
Apr 22, 2014·International Journal of Clinical Pharmacy·Yusuke YagiMitsuhiko Miyamura
Aug 3, 2012·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·James M HarringtonAlvin L Crumbliss
Jul 1, 1994·International Journal of Antimicrobial Agents·H LodeK Borner
Jan 30, 2007·Expert Opinion on Pharmacotherapy·Ioannis P KioumisDavid P Nicolau
Jan 13, 2001·Dermatologic Clinics·N S Sadick
Sep 1, 1994·The Annals of Pharmacotherapy·R D Pryka, G M Haig
Oct 30, 2016·Journal of American College Health : J of ACH·Christopher Woll, P Hunter Spotts
Jan 1, 1990·Diagnostic Microbiology and Infectious Disease·P R Murray, A C Niles
Apr 3, 2012·Applied and Environmental Microbiology·Sangeetha Ananda BaskaranKumar Venkitanarayanan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Antimicrobial Agents and Chemotherapy
R N JonesM A Pfaller
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Y SumitaS Mitsuhashi
© 2022 Meta ULC. All rights reserved